ANDA 40859, held by Baxter Hlthcare Corp. Norepinephrine Bitartrate.
As of Nov 15, 2026, ANDA 40859 (Norepinephrine Bitartrate), held by Baxter Hlthcare Corp, was first approved by FDA on Mar 27, 2012, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 27, 2012 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Norepinephrine BitartrateEQ 1MG BASE/ML ยท injectable;injection | Norepinephrine Bitartrate | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
